scholarly journals Point-of-care screening for heart failure with reduced ejection fraction using artificial intelligence during ECG-enabled stethoscope examination in London, UK: a prospective, observational, multicentre study

Author(s):  
Patrik Bachtiger ◽  
Camille F Petri ◽  
Francesca E Scott ◽  
Se Ri Park ◽  
Mihir A Kelshiker ◽  
...  
Author(s):  
Zubin J Eapen ◽  
Li Liang ◽  
Gregg C Fonarow ◽  
Paul A Heidenriech ◽  
Eric D Peterson ◽  
...  

Background: Outcomes within 30 days of a heart failure (HF) hospitalization are being promoted as metrics of hospital-level quality of care for Medicare beneficiaries. However, few clinically oriented models suitable for use at the point of care have been derived and validated in cohorts of patients with HF with reduced ejection fraction (HF-REF) and HF with preserved ejection fraction (HF-PEF). Methods: Patients 65 years and older who were hospitalized in the American Heart Association's Get With the Guidelines (GWTG)-HF registry were linked with Medicare claims from January 2005 to December 2009. Multivariable models using the generalized estimating equation method were developed for 30-day mortality after admission, 30-day readmission after discharge, and 30-day readmission or death after discharge. Patients transferred to another facility or with in-hospital deaths were excluded from the models of 30-day readmission or readmission/death after discharge. The predictors were selected from a derivation sample (70% of study cohort) and refit using the whole study sample; then, the refit model was validated in an independent derivation sample (30% of study cohort). C-statistic was used to evaluate model performance on discrimination and plots comparing predicted versus observed probability were used to assess calibration. The models were evaluated among patients either with HF-PEF or HF-REF. Results: Among 33,349 patients at 160 hospitals, 3,002 (9.1%) died within 30 days of admission, 7020 (22.8%) were readmitted within 30 days of discharge, and 8,374 (27.2%) either died or were readmitted within 30 days of discharge. The derived risk models (Table shows predictive model for 30-day death or readmission) discriminated well in patients with HF-REF (c-statistic for death: 0.77, readmission: 0.63, death or readmission: 0.67). Similarly, these models maintained their discriminative capacity in patients with HF-PEF (c-statistic for death: 0.75, readmission: 0.61, death or readmission: 0.64). Conclusions: In patients hospitalized at GWTG participating institutions with both preserved and reduced EF, the GWTG-HF predictive models stratify risk for 30-day outcomes in patients with HF. Further study is needed to test effectiveness of integrating these clinical risk models at the point of care.


2012 ◽  
Vol 9 (1) ◽  
pp. 90-95 ◽  
Author(s):  
Otto A Smiseth ◽  
Anders Opdahl ◽  
Espen Boe ◽  
Helge Skulstad

Heart failure with preserved left ventricular ejection fraction (HF-PEF), sometimes named diastolic heart failure, is a common condition most frequently seen in the elderly and is associated with arterial hypertension and left ventricular (LV) hypertrophy. Symptoms are attributed to a stiff left ventricle with compensatory elevation of filling pressure and reduced ability to increase stroke volume by the Frank-Starling mechanism. LV interaction with stiff arteries aggravates these problems. Prognosis is almost as severe as for heart failure with reduced ejection fraction (HF-REF), in part reflecting co-morbidities. Before the diagnosis of HF-PEF is made, non-cardiac etiologies must be excluded. Due to the non-specific nature of heart failure symptoms, it is essential to search for objective evidence of diastolic dysfunction which, in the absence of invasive data, is done by echocardiography and demonstration of signs of elevated LV filling pressure, impaired LV relaxation, or increased LV diastolic stiffness. Antihypertensive treatment can effectively prevent HF-PEF. Treatment of HF-PEF is symptomatic, with similar drugs as in HF-REF.


Author(s):  
Shivananda B Nayak ◽  
Dharindra Sawh ◽  
Brandon Scott ◽  
Vestra Sears ◽  
Kareshma Seebalack ◽  
...  

Purpose: i) To determine the relationship between the cardiac biomarkers ST2 and NT-proBNP with ejection fraction (EF) in heart failure (HF) patients. ii) Assess whether a superiority existed between the aforementioned cardiac markers in diagnosing the HF with reduced EF. iii) Determine the efficacy of both biomarkers in predicting a 30-day cardiovascular event and rehospitalization in patients with HF with reduced EF iv) To assess the influence of age, gender, BMI, anaemia and renal failure on the ST2 and NT-proBNP levels. Design and Methods: A prospective double-blind study was conducted to obtain data from a sample of 64 cardiology patients. A blood sample was collected to test for ST2 and NT-proBNP. An echocardiogram (to obtain EF value), electrocardiogram and questionnaire were also obtained. Results: Of the 64 patients enrolled, 59.4% of the population had an EF less than 40%. At the end of the 30- day period, 7 patients were warded, 37 were not warded, one died and 17 were non respondent. Both biomarkers were efficacious at diagnosing HF with a reduced EF. However, neither of them were efficacious in predicting 30-day rehospitalization. The mean NT-proBNP values being: not rehospitalized (2114.7486) and 30 day rehospitalization (1008.42860) and the mean ST2 values being: not rehospitalized (336.1975), and 30-day rehospitalization. (281.9657). Conclusion: Neither ST2 or NT-proBNP was efficacious in predicting the short- term prognosis in HF with reduced EF. Both however were successful at confirming the diagnosis of HF in HF patients with reduced EF.


Sign in / Sign up

Export Citation Format

Share Document